Merck & Co.’s Covid-19 antiviral pill was endorsed by a World Health Organization panel for patients in the early stages of disease who face high risk of hospitalization.
Merck’s Covid Antiviral Gets WHO Backing for High-Risk Patients
Mental-Health Scars Stay With Survivors Long After Covid Battle
Biden Says Easing of Mask Rules by Governors Is ‘a Tough Call’
Is Covid Becoming Endemic? What Would That Mean?: QuickTake
To read the full content, please log in with your AAPS member username and password.
Sign InNot a member? Learn more and join today!
AAPS Newsmagazine helps pharmaceutical scientists excel in their jobs by providing current science, news, career advice, member recognition, AAPS offerings, and other valuable contemporary information.
Kristen Kalmann, Content Manager 2107 Wilson Blvd. Ste. 200 Arlington, VA 22201
Kira Krewson1-770-810-6982 View the Media Kit
AAPS Customer Service